The Ca50Mg20Zn12Cu18 was assessed with different methods in order to characterize its basic characteristics, and to determine whether the amorphous alloy of such composition would be applicable as an implant material. The XRD analysis was conducted to conclude the structure of the initial material. The Ca50Mg20Zn12Cu18 ingot sample demonstrates crystalline structure containing two main intermetallic phases, however as-cast plates show features of an amorphous material, revealing the characteristic amorphous halo on the x-ray patterns. It was confirmed by the scanning electron microscopy method and fracture images revealing chevron pattern morphology with shell type fracture. Corrosion resistance, was studied using the potentiostatic analysis. The amorphous samples show higher resistance than the crystalline one. Post corrosion surface of the Ca50Mg20Zn12Cu18 alloy exhibits high concentration of magnesium and calcium hydroxides, forming the globular structures in large aggregates of spherical units.
Effects of solution treatment on room temperature mechanical properties were studied in cast AZ91 (Mg-9%Al-1%Zn-0.2%Mn) and AZ91-0.5%Ca alloys. In as-cast state, the Ca addition contributed to the suppression of discontinuous β phase precipitation and the formation of Al2Ca phase. After solution treatment, the AZ91 alloy had only a small amount of Al8Mn5 particles, while β and Al2Ca phases were still present in the Ca-containing alloy. In as-cast state, the AZ91-0.5%Ca alloy showed better yield strength and hardness than the AZ91 alloy. The solution treatment increased the elongation in both alloys, which eventually led to the increase in ultimate tensile strength. The solution treatment resulted in a marked decrease in yield strength and hardness in the AZ91 alloy, whereas the decrements in those values were relatively negligible in the Ca-containing alloy due to the residual phases and solution hardening effect of Ca.